BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23658218)

  • 1. PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.
    Liu Y; Pierce R; Luehmann HP; Sharp TL; Welch MJ
    J Nucl Med; 2013 Jul; 54(7):1135-41. PubMed ID: 23658218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.
    Baba O; Huang LH; Elvington A; Szpakowska M; Sultan D; Heo GS; Zhang X; Luehmann H; Detering L; Chevigne A; Liu Y; Randolph GJ
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):822-836. PubMed ID: 33327748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    Luehmann HP; Detering L; Fors BP; Pressly ED; Woodard PK; Randolph GJ; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2016 Jul; 57(7):1124-9. PubMed ID: 26795285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.
    Luehmann HP; Pressly ED; Detering L; Wang C; Pierce R; Woodard PK; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2014 Apr; 55(4):629-34. PubMed ID: 24591489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography.
    Detering L; Abdilla A; Luehmann HP; Williams JW; Huang LH; Sultan D; Elvington A; Heo GS; Woodard PK; Gropler RJ; Randolph GJ; Hawker CJ; Liu Y
    Mol Pharm; 2021 Mar; 18(3):1386-1396. PubMed ID: 33591187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.
    Liu Y; Abendschein D; Woodard GE; Rossin R; McCommis K; Zheng J; Welch MJ; Woodard PK
    J Nucl Med; 2010 Jan; 51(1):85-91. PubMed ID: 20008978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.
    Nie X; Laforest R; Elvington A; Randolph GJ; Zheng J; Voller T; Abendschein DR; Lapi SE; Woodard PK
    J Nucl Med; 2016 Dec; 57(12):2006-2011. PubMed ID: 27390157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an inflammation imaging tracer,
    Wei L; Petryk J; Gaudet C; Kamkar M; Gan W; Duan Y; Ruddy TD
    J Nucl Cardiol; 2019 Aug; 26(4):1169-1178. PubMed ID: 29417414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury.
    Jin H; Yang H; Liu H; Zhang Y; Zhang X; Rosenberg AJ; Liu Y; Lapi SE; Tu Z
    J Nucl Cardiol; 2017 Apr; 24(2):558-570. PubMed ID: 26843200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.
    Nie X; Randolph GJ; Elvington A; Bandara N; Zheleznyak A; Gropler RJ; Woodard PK; Lapi SE
    Nucl Med Biol; 2016 Sep; 43(9):534-542. PubMed ID: 27372286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% (64)Cu-CANF-Comb.
    Woodard PK; Liu Y; Pressly ED; Luehmann HP; Detering L; Sultan DE; Laforest R; McGrath AJ; Gropler RJ; Hawker CJ
    Pharm Res; 2016 Oct; 33(10):2400-10. PubMed ID: 27286872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis.
    Zhang X; Heo GS; Li A; Lahad D; Detering L; Tao J; Gao X; Zhang X; Luehmann H; Sultan D; Lou L; Venkatesan R; Li R; Zheng J; Amrute J; Lin CY; Kopecky BJ; Gropler RJ; Bredemeyer A; Lavine K; Liu Y
    J Nucl Med; 2024 May; 65(5):775-780. PubMed ID: 38548349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new PET tracer specific for vascular endothelial growth factor receptor 2.
    Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosis.
    Su H; Gorodny N; Gomez LF; Gangadharmath UB; Mu F; Chen G; Walsh JC; Szardenings K; Berman DS; Kolb HC; Tamarappoo BK
    J Nucl Cardiol; 2014 Jun; 21(3):553-62. PubMed ID: 24627345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.